|
|
41
|
|
|
B421H
|
|
|
DAPAGLIFLOZIN 5MG TAB (MCP)
|
|
|
DAPAGLIFLOZIN
|
|
|
DAPAGLIFLOZIN
|
|
|
3X10
|
|
|
A
|
|
|
10.33
|
|
|
0.3443
|
|
|
5MG
|
|
|
TAB
|
|
|
30
|
|
|
BOX
|
|
|
MCP
|
|
|
MACLEODS PHARMACEUTICALS LTD
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
B
|
|
|
Anti-Diabetic
|
|
|
2024-04-01
|
|
|
2024-10-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
N
|
|
|
682018
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
2024-09-19
|